Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland
CONCLUSION: The surveillance system has been successfully initiated and provides a robust set of data for Switzerland by including about 80% (compared with official statistics) of SARS-CoV-2/COVID-19 hospitalised patients, with similar age and comorbidity distributions. It adds detailed information on the epidemiology, risk factors and clinical course of these cases and, therefore, is a valuable addition to the existing mandatory reporting.PMID:33638351 | DOI:10.4414/smw.2021.20475
Source: Swiss Medical Weekly - Category: General Medicine Authors: Amaury Thiabaud Anne Iten Carlo Balmelli Laurence Senn Nicolas Troillet Andreas Widmer Domenica Flury Peter W Schreiber Miriam V ázquez Lauro Damonti Michael Buettcher Danielle Vuichard-Gysin Christoph Kuhm Alexia Cusini Thomas Riedel Yvonne Nussbaumer-O Source Type: research
More News: Asthma | Cancer & Oncology | Cardiology | Cardiovascular | Children | China Health | COVID-19 | Databases & Libraries | Diabetes | Endocrinology | Epidemiology | General Medicine | Heart | Hydroxychloroquine | Hypertension | Intensive Care | International Medicine & Public Health | Liver | Respiratory Medicine | SARS | Statistics | Switzerland Health | Urology & Nephrology | WHO